Collplant Biotechnologies LT
13F holders, Q3 2025 (September 30)1holders
0new positions
0sold out
$2.69avg. 13F price*
At the end of Q3 2025, 1 institutions reported holding Collplant Biotechnologies LT in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holder was Parallel Advisors, LLC ($9K).
- Company
- Collplant Biotechnologies LT
- CUSIP
- 19516R107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q2 2025 → Q3 2025: 1 shares sold, net −1 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Parallel Advisors, LLC | 0.00% | Reduce -0.0% | 3,253 | $9K |
"% of holder's portfolio" is COLLPLANT BIOTECHNOLOGIES LT's weight in each manager's 13F, not the share of Collplant Biotechnologies LT the manager owns.